Whole Genome Sequencing

Powered By Nessi-Seq ¬

Whole genome sequencing (WGS) provides a comprehensive overview of the entire genome and is applicable to a wide range of research fields. It is particularly useful for forward genetic and epigenetic screens, as well as biomarker discovery in precision medicine, disease diagnostics, oncology, microbiome studies, agricultural sciences, virology, pharmacogenomics, and more. 

At WBL, our Whole Genome Sequencing service leverages the Oxford Nanopore Technologies platform to harness the power of long reads. WBL’s proprietary comprehensive bioinformatic WGS reports offer accessible data packages for your analyses.

The Power Of Long-Read Sequencing

WBL’s technology leverages the power of Nanopore long reads. Now equipped with clinically-viable sequencing accuracy and yield, long-read technologies are positioned to advance research and clinical diagnostics. 

Long reads are particularly advantageous when investigating epigenetic modifications and genomic regions that are challenging to sequence with short-read approaches. These include highly repetitive regions, structural variations, and other complexities.

Richer data with WBL’s Whole Genome Sequencing

Acquire whole genome sequencing (WGS) data with proprietary comprehensive reporting. Leveraging Nanopore sequencing technology, obtain unbiased, native strand sequence and epigenetic data.

  • Small Variants (SNPs)
  • Copy Number Variants (CNVs)
  • Short Tandem Repeat Expansions (STRs)
  • Modified Bases (5mC, 5hmC; also 6mA for bacteria)
  • Phasing Data (given the right read depth and length)
  • Structural Variants

Tailored Whole Genome Sequencing:
Custom Coverage for Every Research Need

Coverage can be tailored to the specific goals of your project, balancing cost, accuracy, and the need for detail in variant detection and genome assembly.

Coverage
Potential Application
10x
Population Screening
20x
Structural Variant Discovery
30x
De Novo Assembly
100x
Cancer GenomicsSingle Cell Sequencing

Direct RNA Sequencing:
Applications and Use Cases

*WBL currently only accepts DNA and RNA that are extracted from samples that are not classified as infectious. This policy ensures the safety of our laboratory personnel and compliance with regulatory standards. Please ensure that all samples are appropriately treated and certified as non-infectious before submission. If you have any questions about sample preparation or our safety standards, please contact our support team at: support@wasatchbiolabs.com.

Humans
Animals
Plants
Bacteria*
Virus*

Sample types accepted:

gDNA

WBL: Your Competitive Edge

Maximize your sequencing output with WBL’s leading technology, streamlined bioinformatics pipelines, and expert guidance. WBL’s team of researchers are pioneers in Oxford Nanopore Technologies sequencing with decades of experience in genomics and bioinformatics research.

Speak To A specialist
Speak To A Specialist

Robust Data

NGS 3.0 data with fully streamlined bioinformatics pipelines.

Fast Turnarounds

Results within 14-21 days of your sample’s arrival at the lab.

Expert Guidance

Teams of dedicated researchers and project managers to support your research and development.

Full Visibility

Direct access to an online portal for sample information and batch status at each step of the sequencing process.

Specialized offerings in our next-generationbiolab

Explore our other DNA Services

Targeted Methylation
TARGETED METHYLATION
cfWGMS
cfWGMS
Low-Pass WGMS
Low-Pass WGS

Subscribe to our
Monthly Newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Newsletter Fine Print & Guidelines